Clinical Trials Sponsored by Dr. Yong Cao

Total 718 results

Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of DA-2802 in Chronic Hepatitis B Patients

Hepatitis B， Chronic

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Single-ascending Dose Phase 1 Clinical Trial to Evaluate the Safety and PK of DA-5207 TDS in Healthy Adults

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Unknown

Observational Study to Evaluate the Efficacy and Safety of Suganon Tab. or Sugamet XR Tab.

Diabetes Mellitus, Type 2

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Bioequivalence Study Between "DA-5209 Tab" and "Lixiana Tab"

Healthy

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Non-erosive Reflux Disease

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and Immunogenicity of 'IL-YANG Flu Vaccine Quadrivalent Inj' in Healthy Korean Adults

Influenza, Human
Dong-A ST Co., Ltd.

Completed

A Study to Investigate the Bioequivalence Test of DA-1229_01(A) at Fasting State

Type2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Study to Compare the Efficacy and Safety of CELBESTA® and CELEBREX® in Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Efficacy and Safety of DA-3002 in Short Children Borns SGA. (SGA)

Infant, Small for Gestational Age

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Study of Motilitone to Treat Functional Dyspepsia

Dyspepsia

United States
Dong-A ST Co., Ltd.

Completed

Phase IV Clinical Trial to Investigate the Effect on Blood Glucose of Evogliptin in Patients With Type 2 Diabetes(EVERGREEN)

Type2 Diabetes

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Unknown

Clinical Study of Decitabine and Paclitaxel Combination Therapy

Advanced Breast Cancer

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5 mg and Pioglitazone 30 mg

Type 2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of Evogliptin 5mg and Glimepiride 4mg

Type2 Diabetes

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Baracle Tab. ® Versus Baraclude Tab.® for Patients With HBeAg Chronic Hepatitis B

HBeAg-Positive Chronic Hepatitis B

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Unknown

Drug-drug Interaction Between Aceclofenac 200 mg and Esomeprazole 20 mg in Healthy Male Volunteers (DW6008)

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Trial to Assess the Safety and Pharmacokinetics of DA-2802 319mg and Viread 300mg in Healthy Male Volunteers

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

To Determine the Efficacy and Safety of DW1029M on Microalbuminuria in Patients With Diabetic Nephropathy

Diabetic Nephropathy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Evaluation of Pharmacokinetic/Pharmacodynamic Properties and Safety of Leucostim® Compared to Neupogen® in Healthy Adult Volunteers

Healthy

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Dual Therapy With High Doses of Ilaprazole and Amoxicillin for Helicobacter Pylori Infection

Helicobacter Infections

Korea, Republic of
Dong-A ST Co., Ltd.

Unknown

To Investigate the Pharmacokinetics of EPORON® and EPREX® After Subcutaneous Administration in Healthy Male Volunteers

Healthy

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Efficacy and Safety of Basic Triple Therapy Including Ilaprazole on the First Line Eradication Treatment of H.Pylori

Helicobacter Infections

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

A Clinical Trial to Investigate Safety/Tolerability and Pharmacokinetics of DA-1229_01(Evogliptin/Metformin XR 2.5/500 mg x 2 Tablets) Compared to Co-administration of Evogliptin 5 mg and Metformin XR 1000 mg in Healthy Male Volunteers

Type 2 Diabetes Mellitus

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

Hyperlipidemia

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

Pharmacokinetic Profiles of Metformin With DW1029M (PMD)

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

the Pharmacokinetic Profiles of Linagliptin With DW1029M (PLID)

Healthy

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Completed

the Pharmacokinetic Profiles of Losartan With DW1029M (PLD)

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

Androgenetic Alopecia

Korea, Republic of
Dong-A ST Co., Ltd.

Unknown

A Study to Evaluate the Efficacy and Safety of DA-5204

Acute Gastritis | Chronic Gastritis

Korea, Republic of
Dong-A ST Co., Ltd.

Unknown

Microtracer Study to Establish Absolute Bioavailability and the Absorption, Metabolism, Excretion of DA-1229

Healthy

United Kingdom
Dong-A ST Co., Ltd.

Completed

Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia (PEG-G-CSF)

Chemotherapy Induced Neutropenia

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Phase III Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced Neutropenia (PEG-G-CSF)

Chemotherapy Induced Neutropenia

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

The Safety/Tolerability and Pharmacokinetics (PKs) of Naftopidil in Korean Healthy Male Volunteers

Healthy

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Immunogenicity and Safety Study of Inactivated Split Influenza Vaccine' in Healthy Korean Male Subjects

Healthy

Korea, Republic of
Kwang Dong Pharmaceutical co., ltd.

Completed

A Phase 2 Study to Compare the Efficacy and Tolerability of Tarafenacin 0.2 mg and Tarafenacin 0.4 mg to Placebo in Patients Suffering From Overactive Bladder.

Overactive Bladder

Korea, Republic of
Dong-A PharmTech Co., Ltd.

Completed

A Study of DA-8159 in Subjects With Erectile Dysfunction

Erectile Dysfunction

United States
Dong-A ST Co., Ltd.

Not yet recruiting

Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control

Type 2 Diabetes

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

Peptic Ulcer

Korea, Republic of
Dong Wha Pharmaceutical Co. Ltd.

Not yet recruiting

This Study is to Compare and Evaluate the Safety and Pharmacokinetic Characteristics (PK) After Administration of DW6014 and Each Component in Healthy Adult Volunteers in Fed Condition.

DW6014

Korea, Republic of
Dong-A ST Co., Ltd.

Not yet recruiting

Phamacokinetics and Safety Profiles of DA-1229_01 5/1000mg in Healthy Subjects at Fasting State

Healthy

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Not yet recruiting

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Pharmacokinetics

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Recruiting

Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease

Parkinson Disease

France
Dong-A ST Co., Ltd.

Completed

A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

Healthy | Renal Impairment

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Active, not recruiting

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

Pharmacokinetics

Korea, Republic of
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate the Safety and the Pharmacokinetics of IY-NT-T

Pharmacokinetics

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Evaluate the Effect of Clarithromycin/Rifampicin on the Pharmacokinetics of DA-8010 in Healthy Adults

Healthy

Korea, Republic of
Dong-A ST Co., Ltd.

Completed

Drug Interactions When DA-8010 is Co-administered With Paroxetine or Mirabegron in Healthy Adults

Healthy

Korea, Republic of
Yung Sheng Optical Co., Ltd.

Completed

Clinical Evaluation of the Safety and Efficacy of Yung Sheng 38% Color Contact Lens

Myopia
Yung Sheng Optical Co., Ltd.

Completed

A Prospective, Randomized, Double-blind, Parallel, Active-controlled Clinical Study of Silicone Hydrogel Monthly Soft Contact Lens for the Safety and Effectiveness in Visual Correction.

Myopia

Taiwan
Il-Yang Pharm. Co., Ltd.

Completed

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

Drug Interaction Potentiation

Korea, Republic of

3

Subscribe